Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.07 +5.02%

+$0.05 today

Market cap
$213.79M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 10.47M

Average 5.64M

QSI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Quantum-Si incorporatedNASDAQ: QSI

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 216.47M shares rose 18.7% year over year, behind the +31.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 9.5% from the prior quarter. Over 3 fiscal years it compounded at +12.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +18.7% toward the trailing-twelve-month pace of +31.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
216.47M+9.5% QoQ
Last fiscal yearDec 2025
197.77M+38.1% YoY
LTMMar 2026
201.73M+31.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.7%——
1 year+38.1%——
3-year CAGR+12.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
197.77M USD
Year-over-year change
+38.1%
4-year CAGR
+25.6%

Weighted Avg Shares vs competitors

How QSI compares with its peers on the latest reported figures

  • QSI's LTM Mar 2026 weighted avg shares of 201.73M shares is the 2nd highest of the 11 companies compared; the peer median is 98.63M shares.
  • Its year-over-year change of +31.6% is the 4th highest of 10, against a peer median of +25.2%.
  • Over three fiscal years its annual growth of +12.4% compares with a peer median of +33.6%.
QSI Competitors Peer median
Weighted Avg Shares for QSI and competitors
Company Period LTM YoY 3-year CAGR
AUTLAutolus Therapeutics plcLTM Mar 2026266.14M +0.0%+41.0%
QSIQuantum-Si incorporatedLTM Mar 2026201.73M +31.6%+12.4%
ANNXAnnexon, Inc.LTM Mar 2026161.69M +14.3%+41.6%
ADCTADC Therapeutics S.A.LTM Mar 2026138.66M +34.3%+17.6%
RCKTRocket Pharmaceuticals, Inc.LTM Mar 2026111.46M +12.7%+17.7%
ALTAltimmune, Inc.LTM Mar 202698.99M +37.1%+23.4%
SLDBSolid Biosciences Inc.LTM Mar 202698.27M +94.3%+117.4%
DBVTDBV Technologies S.A.LTM Mar 202688.66M -7.8%+3.7%
AURAAura Biosciences, Inc.LTM Mar 202662.93M +26.5%+26.3%
ENGNenGene Holdings Inc.LTM Apr 202659.85M +25.2%+47.9%
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 202619.77M —+92.6%
Peer median (excluding QSI) 98.63M+25.2%+33.6%

Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue001.08M3.06M2.44M
Cost of Revenue00594K1.46M1.28M
Gross Profit00488K1.6M1.15M
Gross Margin——45.1%52.3%47.3%
Research & Development46.58M72.06M67.03M59.64M53.76M
Selling, General & Admin50.33M42.3M44.63M50.54M44.75M
Operating Expenses96.91M123.84M111.66M110.18M98.51M
Depreciation & Amortization1.04M2.58M4.16M4.6M4.45M
EBITDA(93.94M)(111.77M)(91.8M)(96.35M)(96.83M)
EBITDA Margin——-8484.7%-3150.8%-3974.8%
Operating Income(96.91M)(123.84M)(111.17M)(108.58M)(97.36M)
Operating Margin——-10274.6%-3550.6%-3996.7%
Interest Income00008.96M
Interest Expense5K0000
Other Income / Expenses1.92M(8.6M)15.21M7.63M(3.92M)
Income Before Tax(94.99M)(132.44M)(95.96M)(100.95M)(101.28M)
Pre-Tax Margin——-8868.8%-3301.2%-4157.7%
Income Tax Expense00056K58K
Net Income(94.99M)(132.44M)(95.96M)(101.01M)(101.34M)
Net Margin——-8868.8%-3303.0%-4160.1%
EPS (Basic)(1.19)(0.95)(0.68)(0.71)(0.51)
EPS (Diluted)(1.19)(0.95)(0.68)(0.71)(0.51)
Weighted Avg Shares79.58M139.26M141.3M143.2M197.77M
Weighted Avg Shares (Diluted)79.58M139.26M141.3M143.2M197.77M

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.